PGNY
Progyny Inc

2,451
Mkt Cap
$2.11B
Volume
1.45M
52W High
$28.75
52W Low
$17.98
PE Ratio
38.84
PGNY Fundamentals
Price
$24.12
Prev Close
$24.53
Open
$24.51
50D MA
$25.71
Beta
0.63
Avg. Volume
1.36M
EPS (Annual)
$0.5693
P/B
3.77
Rev/Employee
$1.72M
Loading...
Loading...
News
all
press releases
Kornitzer Capital Management Inc. KS Sells 85,000 Shares of Progyny, Inc. $PGNY
Kornitzer Capital Management Inc. KS lessened its position in Progyny, Inc. (NASDAQ:PGNY - Free Report) by 16.6% in the third quarter, according to the company in its most recent filing with the...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Progyny (NASDAQ:PGNY) Upgraded by Citizens Jmp to "Market Outperform" Rating
Citizens Jmp upgraded shares of Progyny from a "market perform" rating to a "market outperform" rating and set a $30.00 target price for the company in a research report on Tuesday...
MarketBeat·9d ago
News Placeholder
Short Interest in Progyny, Inc. (NASDAQ:PGNY) Declines By 23.3%
Progyny, Inc. (NASDAQ:PGNY - Get Free Report) saw a large drop in short interest during the month of December. As of December 31st, there was short interest totaling 4,348,246 shares, a drop of 23.3...
MarketBeat·11d ago
News Placeholder
Zacks Industry Outlook Highlights Medpace, Enhabit and Progyny
Medpace anchors a cautious medical services outlook as digital health tailwinds help select players offset workforce pressures.
Zacks·17d ago
News Placeholder
Progyny, Inc. (PGNY) Soars to 52-Week High, Time to Cash Out?
Progyny (PGNY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks·20d ago
News Placeholder
3 Medical Service Industry Stocks Set to Tackle Workforce Challenges
Medical services stocks like MEDP, EHAB and PGNY benefit from tech-driven care models even as staffing gaps pressure margins.
Zacks·20d ago
News Placeholder
Progyny (NASDAQ:PGNY) Hits New 1-Year High After Analyst Upgrade
Progyny (NASDAQ:PGNY) Sets New 12-Month High Following Analyst Upgrade...
MarketBeat·21d ago
News Placeholder
Progyny (NASDAQ:PGNY) Stock Rating Upgraded by Truist Financial
Truist Financial raised Progyny from a "hold" rating to a "buy" rating and set a $34.00 price objective for the company in a research note on Thursday...
MarketBeat·21d ago
News Placeholder
Progyny (NASDAQ:PGNY) Rating Increased to Strong-Buy at Zacks Research
Zacks Research raised shares of Progyny from a "hold" rating to a "strong-buy" rating in a research report on Thursday...
MarketBeat·27d ago
News Placeholder
Progyny (NASDAQ:PGNY) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen raised shares of Progyny from a "hold" rating to a "buy" rating in a research report on Saturday...
MarketBeat·27d ago
<
1
2
...
>

Latest PGNY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.